PGIM India Healthcare Fund - Regular Plan - IDCW Option
Category: Equity: Sectoral-Pharma and Healthcare
Launch Date: 19-11-2024
AUM:
₹ 111.81 Cr
Expense Ratio
2.37%
Benchmark
BSE Healthcare TRI
ISIN
INF663L01Z86
Minimum Investment
5000.0
Minimum Topup
1000.0
Minimum SIP Amount
1000
Fund Manager
Mr. Anandha Padmanabhan, Mr. Utsav Mehta, Mr. Vivek Sharma and Mr. Puneet Pal
| Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
|---|---|---|---|
| PGIM India Healthcare Fund - Regular Plan - IDCW Option | - | - | - |
| Benchmark | - | - | - |
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
If you invested in this fund:
In the past (time duration):
Total value today:
0
Returns:
0%
Overview
NAV
10.01
Last change
-0.02 (-0.1998%)
Fund Size (AUM)
₹ 111.81 Cr
Performance
0.3% (Inception)
Asset Allocation
Equity
Debt
Others
Nav Movement
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
Fund Manager
Mr. Anandha Padmanabhan, Mr. Utsav Mehta, Mr. Vivek Sharma and Mr. Puneet Pal
Riskometer
Very High
Top 10 Holdings
| Company | Holdings (%) |
|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/- | 12.4 |
| DIVIS LABORATORIES LIMITED EQ NEW RS. 2/- | 8.62 |
| MAX HEALTHCARE INSTITUTE LIMITED EQ | 7.94 |
| Dr. Reddys Laboratories Ltd | 6.3 |
| ASTER DM HEALTHCARE LIMITED EQ | 5.43 |
| MANKIND PHARMA LIMITED EQ NEW FV RE. 1/- | 4.66 |
| TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/- | 4.08 |
| ABBOTT INDIA LIMITED EQ | 3.79 |
| Krishna Institute Of Medical Sciences Limited | 3.53 |
| AJANTA PHARMA LIMITED EQ NEW FV RS. 2/- | 3.28 |
Sector Allocation
| Sector | Holdings (%) |
|---|---|
| Healthcare | 86.58 |
| Financial Services | 6.08 |
| Chemicals | 2.47 |
| Information Technology | 1.84 |